Back to Search
UMAR MAHMOOD, DO
DO
Interventional Pain Medicine Physician
NPI: 1346506185IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pain Medicine (Physical Medicine & Rehabilitation) Physician
Physical Medicine & Rehabilitation — Pain Medicine
Code: 2081P2900X
585(TX)
Interventional Pain Medicine PhysicianPrimary
Pain Medicine — Interventional Pain Medicine
Code: 208VP0014X
R8780(TX)
CMS Specialties
PrimaryINTERVENTIONAL PAIN MANAGEMENT
Education
CHICAGO COLLEGE OF OSTEOPATHY
Class of 2012
Research & Publications (20)
Upconverting luminescent nanomaterials: application to in vivo bioimaging.
PMID 19585016·Chem Commun (Camb)·2009
7-preclinical
Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis.
PMID 19240248·Cancer Prev Res (Phila)·2009
7-preclinical
Quantitative endovascular fluorescence-based molecular imaging through blood of arterial wall inflammation.
PMID 19474377·Radiology·2009
7-preclinical
Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model.
PMID 19135233·Gynecol Oncol·2009
7-preclinical
Abrogation of antibody-induced arthritis in mice by a self-activating viridin prodrug and association with impaired neutrophil and endothelial cell function.
PMID 19644878·Arthritis Rheum·2009
7-preclinical
Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo.
PMID 19007918·Bone·2009
7-preclinical
Design and demonstration of a small-animal up-conversion imager.
PMID 19104605·Opt Express·2008
7-preclinical
Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy.
PMID 18647846·Radiology·2008
7-preclinical
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma.
PMID 18416599·PLoS Med·2008
7-preclinical
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.
PMID 18927287·Clin Cancer Res·2008
7-preclinical
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
PMID 19029981·Nat Med·2008
7-preclinical
In vivo quantitative microvasculature phenotype imaging of healthy and malignant tissues using a fiber-optic confocal laser microprobe.
PMID 18633456·Transl Oncol·2008
8-other
A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification.
PMID 19033657·J Clin Invest·2008
7-preclinical
Current and Future Imaging Paradigms in Colorectal Cancer.
PMID 18516215·Semin Colon Rectal Surg·2007
8-other
Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk.
PMID 17646407·J Exp Med·2007
7-preclinical
Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo.
PMID 17671203·Cancer Res·2007
7-preclinical
Multiparameter noninvasive assessment of treatment susceptibility, drug target inhibition and tumor response guides cancer treatment.
PMID 17683072·Int J Cancer·2007
7-preclinical
Quantitative real-time catheter-based fluorescence molecular imaging in mice.
PMID 17940307·Radiology·2007
7-preclinical
Imaging of the pediatric airway using optical coherence tomography.
PMID 18322424·Laryngoscope·2007
3-trial
Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice.
PMID 17507718·Radiology·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 12000 Richmond Ave Ste 330
Houston, TX 77082 - Phone
- (832) 895-6012
Quick Facts
- NPI
- 1346506185
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile